Google Health's AI outperforms radiologists at breast cancer...

An artificial intelligence (AI) system from Google Health can identify breast cancer more accurately than radiologists, according to research.

FDA hastily approves Daiichi Sankyo/AZ's cancer drug, weeks ...

The FDA has approved an advanced breast cancer drug from AstraZeneca and Daiichi Sankyo in super-quick time.

AZ sells ex-US rights to old cancer drugs Arimidex and Casod...

For several years AstraZeneca has been selling off rights to its older drugs to raise cash as it develops a new generation of drugs, and this pattern has continued as it sold its Arimidex a

AZ and Daiichi Sankyo's breast cancer drug delays progressio...

AstraZeneca had to ask shareholders for $3.5 billion in extra cash to finance an R&D tie-up with Daiichi Sankyo for an experimental breast cancer drug – and so far it looks like money w

Mylan and Biocon launch Herceptin biosimilar in US

Mylan and Biocon have launched their Herceptin biosimilar Ogivri in the US, the second challenger to Roche’s breast and stomach cancer blockbuster.

NICE backs Ibrance for breast cancer via Cancer Drugs Fund